Monoclonal Antibody News and Research

RSS
Monoclonal antibodies (MAbs) are produced from a single B cell clone and can bind to a single type of antigen binding site. MAbs are homogenous antibodies that cannot form lattices with monomeric proteins as they can bind to only a single epitope on the antigen. Developed in the 1970s, MAbs can be produced against any given substance. Thus they can be used to detect and purify any substance of interest. This has made MAbs a powerful tool of molecular biology, biochemistry, and medicine.
KaloBios’ KB001 shows promise against Pa pneumonia

KaloBios’ KB001 shows promise against Pa pneumonia

Merck Serono, Compugen announce establishment of Neviah Genomics

Merck Serono, Compugen announce establishment of Neviah Genomics

AbGenomics raises $11 million in current financing round

AbGenomics raises $11 million in current financing round

GBM patients with CNP subtype may have less aggressive subtype of cancer

GBM patients with CNP subtype may have less aggressive subtype of cancer

SDIX advanced Genomic Antibody Technology to be highlighted at BIO International Convention

SDIX advanced Genomic Antibody Technology to be highlighted at BIO International Convention

Single-dose vaccine for treatment of cocaine addiction

Single-dose vaccine for treatment of cocaine addiction

New clinical data for ZEVALIN Injection for intravenous use presented at 17th EHA Congress

New clinical data for ZEVALIN Injection for intravenous use presented at 17th EHA Congress

Novel strategy for neutralizing unwanted molecules and clearing them from the body

Novel strategy for neutralizing unwanted molecules and clearing them from the body

BEAMing DNA blood testing technology detects drug resistance in colorectal cancer patients early

BEAMing DNA blood testing technology detects drug resistance in colorectal cancer patients early

Theraclone Sciences commences TCN-202 Phase 1 trial in CMV infection

Theraclone Sciences commences TCN-202 Phase 1 trial in CMV infection

Laparoscopy technique lights up invisible metastases

Laparoscopy technique lights up invisible metastases

Cancers often recur after treatment with single drugs that “target” tumor cells’ genetic pathways

Cancers often recur after treatment with single drugs that “target” tumor cells’ genetic pathways

Acorda commences AMPYRA clinical study for post-stoke deficits

Acorda commences AMPYRA clinical study for post-stoke deficits

Igenica raises $33M in Series C round of funding

Igenica raises $33M in Series C round of funding

Genzyme files LEMTRADA sBLA and MAA with FDA, EMA for treatment of RMS

Genzyme files LEMTRADA sBLA and MAA with FDA, EMA for treatment of RMS

Genentech receives FDA approval for Perjeta to treat HER2-positive metastatic breast cancer

Genentech receives FDA approval for Perjeta to treat HER2-positive metastatic breast cancer

STELARA effectively reduces signs and symptoms of active psoriatic arthritis

STELARA effectively reduces signs and symptoms of active psoriatic arthritis

BioInvent, ThromboGenics to regain global rights to TB-403 from Roche

BioInvent, ThromboGenics to regain global rights to TB-403 from Roche

New PD-1 blocking antibody shows promise against advanced kidney cancer

New PD-1 blocking antibody shows promise against advanced kidney cancer

Oncothyreon announces data from two clinical trials of PX-866 at ASCO meeting

Oncothyreon announces data from two clinical trials of PX-866 at ASCO meeting

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.